3CD-30539-76782
3 vaccinations
4 coded responses
22 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 200 / DC
- Registered
- 2022-11-30
- Relationship
- Child or adolescent in my care
- Guardian
- HS5-28845-47580
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-11-05
Dose 1 — Pfizer-BioNTech
-
2022-11-26
Dose 2 — Pfizer-BioNTech
-
2022-11-30
Registered in v-safe
-
2022-11-30
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Nasal congestion, Rhinorrhoea — Feeling: Poor · Fever · Irritability/crying · Be unable to work or attend schoolFree text: Congestion/runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-12-01
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Fever · Irritability/crying · Be unable to work or attend schoolFree text: Congestion/runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-12-02
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Poor · Fever · Irritability/crying · Be unable to work or attend schoolUnder 3 check-in
-
2022-12-03
Survey response — day 7, dose 2, under 3MedDRA: Respiratory tract congestion — Feeling: GoodFree text: CongestionMedDRA releases: 2024-11 · check-in free text available
- 2022-12-10
- 2022-12-17
-
2022-12-24
Health check-in — day 28, dose 2, under 3Feeling: GoodFree text: Runny nose/congestionUnder 3 check-in · check-in free text available
- 2022-12-31
- 2023-01-07
-
2023-01-21
Dose 3 — Pfizer-BioNTech
- 2023-01-22
- 2023-01-23
- 2023-01-24
- 2023-01-25
- 2023-01-26
- 2023-01-27
- 2023-01-28
-
2023-02-04
Survey response — day 14, dose 3, under 3MedDRA: Diarrhoea, Rhinorrhoea, Vomiting — Feeling: Fair · Be unable to work or attend schoolMedDRA releases: 2024-11
- 2023-02-11
- 2023-02-18
- 2023-02-27
- 2023-03-04
- 2023-04-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-11-05 | Pfizer-BioNTech | No |
| 2 | 2022-11-26 | Pfizer-BioNTech | No |
| 3 | 2023-01-21 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): Congestion/runny nose
Systemic reaction (other): Congestion/runny nose
Release 12 (Under 3) — day 7, dose 2, under 3
Systemic reaction (other): Congestion
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: Runny nose/congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release